Small biotech niche NDB Bio operates with a small team (2-10 employees) yet offers specialized histology and immunohistochemistry services for human and veterinary tissues, indicating a focused, high-skill service provider ideal for targeted outreach to research labs and biotech startups needing expert translational assays.

End-to-end solutions The company provides start-to-finish in situ protein detection and custom multiplexed immunoassays, presenting a compelling cross-sell opportunity to clients who require project design, execution, and data analysis under one partner.

Open platform versatility Open platform technology used for multiplex immunoassays suggests flexibility to support a variety of research programs, enabling conversations about rapid method customization and compatibility with multiple targets and sample types.

Global quality signals Team includes seasoned scientists and pathologists with translational research experience, which can be leveraged to position NDBbio as a credible provider for biomarker testing and assay development for both academic and government clients.

Growth and partnerships Revenue in the $1M-$10M range and digital presence on multiple platforms indicate growth potential; potential sales angles include expanding into collaborations with mid-sized biotech firms, CROs, and government research programs seeking specialized histology services.